Health · Pharma & Biotech · 2 hrs ago
Zoetis targets Japan with 12 new pet medicines
Zoetis plans to bring 12 new medicines for dogs and cats to Japan, including cancer treatments.
The US company is the world’s largest animal-medicine maker, and Japan is a mature market where it expects demand.
A German animal-medicine company has developed a diabetes drug for cats by adapting a medicine used in people.
Longer-lived pets are increasing demand for treatment of cancer and chronic illnesses.
The market is growing as owners seek care for diseases that become more common as pets age.
The companies are responding with medicines for pets’ health needs, but the available information does not say when Zoetis’s planned products will launch in Japan.
Zoetis plans to launch 12 medicines for dogs and cats in Japan, including cancer treatments.
The US animal-health company says Japan’s mature animal-medicine market offers expected demand.
Demand is rising for treatments for diseases common in ageing pets.
A German animal-health company has developed a diabetes medicine for cats by adapting a human medicine.
- Who
- Zoetis, a major US animal-health company.
- What
- It aims to launch 12 new medicines for dogs and cats in Japan, including cancer drugs.
- When
- Not stated.
- Where
- Japan.
- Why
- Demand for treatment of diseases in ageing dogs and cats is growing.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- New medicines
- 12 products for dogs and cats
- Target market
- Japan
- Company
- Zoetis, a major US animal-health company
- Treatment area
- Cancer medicines are among the planned products
- Cat diabetes
- A German animal-health company developed a medicine by adapting a human medicine
1 source
What people are saying
We will also launch 12 medicines being developed for dogs and cats in Japan. Japan's animal-medicine market is mature, and demand can be expected.